Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The polyp biopsy market has demonstrated impressive growth in recent years and continues to show promising potential for expansion. Driven by advancements in technology and rising disease prevalence, this sector is set to experience notable revenue increases over the forecast period. Let’s explore the current market size, key growth drivers, emerging trends, major players, and regional dynamics shaping this industry.

Polyp Biopsy Market Size and Projected Growth Through 2030

The market for polyp biopsy has witnessed substantial growth and is projected to increase from $1.39 billion in 2025 to $1.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This upward trend in recent years is linked to the rising incidence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, expanded screening programs, greater awareness about early diagnosis, and the growth of specialty clinics. Looking ahead, the market is expected to grow robustly, reaching $2.06 billion by 2030 at a CAGR of 8.2%. Key factors propelling this expansion include the adoption of AI-assisted biopsy procedures, minimally invasive techniques, wider use in hospitals and diagnostic labs, integration with imaging and cloud technologies, and the development of innovative biopsy tools. Leading market segments during this period include colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (EMR).

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

Factors Fueling Demand Growth in the Polyp Biopsy Market

One of the primary drivers of the polyp biopsy market is the increasing prevalence of colorectal cancer worldwide. This cancer originates in the colon or rectum due to abnormal proliferation of epithelial cells lining the large intestine, with the potential to invade surrounding tissues and metastasize. The rise in colorectal cancer cases is largely influenced by dietary habits high in processed foods and low fiber content, which promote chronic inflammation and disrupt gut microbiota, fostering the development of precancerous lesions. Polyp biopsy plays a crucial role in early detection and histopathological examination of suspicious lesions, thereby facilitating timely intervention and preventing disease progression.

To illustrate the impact, the American Cancer Society (ACS) estimates that in 2025, there will be approximately 107,320 new colon cancer cases and 46,950 rectal cancer diagnoses in the United States, with nearly 52,900 deaths attributed to these conditions. This significant disease burden underscores the vital need for improved diagnostic tools, which in turn is accelerating demand within the polyp biopsy market.

Access The Complete Polyp Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Product and Application Segments Defining the Polyp Biopsy Market

The polyp biopsy market is categorized across several important segments for precise market analysis:

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Furthermore, subcategories deepen the segmentation: Colonoscopy is divided into diagnostic and therapeutic types; Colposcopy-Directed Biopsy includes cervical, vaginal, and vulvar biopsies; Esophagogastroduodenoscopy is split into diagnostic and therapeutic procedures.

Innovations and Trends Advancing the Polyp Biopsy Market

Key players in this market are heavily investing in innovative technologies such as AI-assisted detection systems, which enhance the identification of colorectal polyps and facilitate early cancer detection. These AI systems analyze medical imaging in real time, flagging abnormalities to assist clinicians in making informed decisions without conducting therapeutic procedures during detection.

For example, in September 2024, Odin Medical Ltd., a US medical technology firm affiliated with Olympus Corporation, introduced CADDIE—a cloud-based AI endoscopic platform. This solution processes colonoscopy video feeds in real time to highlight potential colorectal polyps, enabling endoscopists to improve adenoma detection rates. Clinical trials have demonstrated that CADDIE enhances diagnostic accuracy without extending procedure times or increasing risks, highlighting its potential to transform patient care and outcomes.

Key Industry Players Influencing the Polyp Biopsy Market

The competitive landscape of the polyp biopsy market includes prominent corporations such as Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., and Innovia Medical. These companies are at the forefront of driving innovation and expanding market reach.

Regional Market Dynamics and Growth Outlook

In 2025, North America held the largest share of the polyp biopsy market, owing to advanced healthcare infrastructure and high disease awareness. However, the Asia-Pacific region is predicted to be the fastest-growing market throughout the forecast period, driven by rising healthcare investments and increasing prevalence of gastrointestinal cancers. The comprehensive geographic analysis also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a global perspective on market trends and opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.